1. Muzzio M, Huang Z, Hu SC, Johnson WD, McCormick DL, Kapetanovic IM: Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs. J Pharm Biomed Anal. 2012 Feb 5;59:201-8. doi: 10.1016/j.jpba.2011.10.023. Epub 2011 Oct 25. [PubMed:22079044 ]
  2. Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ, Brown K: Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 2010 Oct 1;70(19):7392-9. doi: 10.1158/0008-5472.CAN-10-2027. Epub 2010 Sep 14. [PubMed:20841478 ]
  3. Wenzel E, Soldo T, Erbersdobler H, Somoza V: Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol Nutr Food Res. 2005 May;49(5):482-94. [PubMed:15779067 ]
  4. Herath W, Khan SI, Khan IA: Microbial metabolism. Part 14. Isolation and bioactivity evaluation of microbial metabolites of resveratrol. Nat Prod Res. 2013;27(16):1437-44. doi: 10.1080/14786419.2012.722089. Epub 2012 Sep 6. [PubMed:22950854 ]
  5. Andres-Lacueva C, Macarulla MT, Rotches-Ribalta M, Boto-Ordonez M, Urpi-Sarda M, Rodriguez VM, Portillo MP: Distribution of resveratrol metabolites in liver, adipose tissue, and skeletal muscle in rats fed different doses of this polyphenol. J Agric Food Chem. 2012 May 16;60(19):4833-40. doi: 10.1021/jf3001108. Epub 2012 May 7. [PubMed:22533982 ]
  6. Urpi-Sarda M, Jauregui O, Lamuela-Raventos RM, Jaeger W, Miksits M, Covas MI, Andres-Lacueva C: Uptake of diet resveratrol into the human low-density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry. Anal Chem. 2005 May 15;77(10):3149-55. [PubMed:15889903 ]
  7. Rotches-Ribalta M, Andres-Lacueva C, Estruch R, Escribano E, Urpi-Sarda M: Pharmacokinetics of resveratrol metabolic profile in healthy humans after moderate consumption of red wine and grape extract tablets. Pharmacol Res. 2012 Nov;66(5):375-82. doi: 10.1016/j.phrs.2012.08.001. Epub 2012 Aug 10. [PubMed:22906730 ]
  8. Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE: Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1246-52. [PubMed:17548692 ]
  9. Yu C, Shin YG, Chow A, Li Y, Kosmeder JW, Lee YS, Hirschelman WH, Pezzuto JM, Mehta RG, van Breemen RB: Human, rat, and mouse metabolism of resveratrol. Pharm Res. 2002 Dec;19(12):1907-14. [PubMed:12523673 ]
  10. Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, Brown K, Steward WP, Gescher AJ, Brenner DE: Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res. 2010 Nov 15;70(22):9003-11. doi: 10.1158/0008-5472.CAN-10-2364. Epub 2010 Oct 8. [PubMed:20935227 ]
  11. Rotches-Ribalta M, Urpi-Sarda M, Llorach R, Boto-Ordonez M, Jauregui O, Chiva-Blanch G, Perez-Garcia L, Jaeger W, Guillen M, Corella D, Tinahones FJ, Estruch R, Andres-Lacueva C: Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method. J Chromatogr A. 2012 Nov 23;1265:105-13. doi: 10.1016/j.chroma.2012.09.093. Epub 2012 Oct 1. [PubMed:23089514 ]